455 results on '"Zheng, Bo-Jian"'
Search Results
152. Monoclonal Antibody-Based Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Sensitivity of the Nucleocapsid Protein in Acute-Phase Sera of Severe Acute Respiratory Syndrome Patients
- Author
-
Di, Biao, primary, Hao, Wei, additional, Gao, Yang, additional, Wang, Ming, additional, Wang, Ya-di, additional, Qiu, Li-wen, additional, Wen, Kun, additional, Zhou, Duan-hua, additional, Wu, Xin-wei, additional, Lu, En-jie, additional, Liao, Zhi-yong, additional, Mei, Ya-bo, additional, Zheng, Bo-jian, additional, and Che, Xiao-yan, additional
- Published
- 2005
- Full Text
- View/download PDF
153. Prophylactic and Therapeutic Effects of Small Interfering Rna Targeting Sars-Coronavirus
- Author
-
Zheng, Bo-jian, primary, Guan, Yi, additional, Tang, Qingquan, additional, Cheng, Du, additional, Xie, Frank Y, additional, He, Ming-Liang, additional, Chan, Kwok-Wah, additional, Wong, Kin-Ling, additional, Lader, Eric, additional, Woodle, Martin C, additional, Lu, Patrick Y, additional, Li, Baojian, additional, and Zhong, Nanshan, additional
- Published
- 2003
- Full Text
- View/download PDF
154. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice
- Author
-
Zheng, Bo Jian, primary, Ng, Mun Hon, additional, Chan, Kwok Wah, additional, Tam, Sidney, additional, Woo, Patrick C. Y., additional, Ng, Sze Park, additional, and Yuen, Kwok Yung, additional
- Published
- 2002
- Full Text
- View/download PDF
155. Peripheral γδ T‐cell deficit in nasopharyngeal carcinoma
- Author
-
Zheng, Bo Jian, primary, Ng, Sze Park, additional, Chua, Daniel T.T., additional, Sham, Jonathan S.T., additional, Kwong, Dora L.W., additional, Lam, Clarence K., additional, and Ng, Mun Hon, additional
- Published
- 2002
- Full Text
- View/download PDF
156. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
- Author
-
Cheng, Wei-min, primary, Chan, Kwok Hung, additional, Chen, Hong-lin, additional, Luo, Rui-xian, additional, Ng, S. Park, additional, Luk, Winsie, additional, Zheng, Bo-jian, additional, Ji, Ming-fang, additional, Liang, Jin-sheng, additional, Sham, Jonathan S.T., additional, Wang, De-Kun, additional, Zong, Yong-sheng, additional, and Ng, Mun Hon, additional
- Published
- 2002
- Full Text
- View/download PDF
157. Anti-tumor effects of human peripheral ?? T cells in a mouse tumor model
- Author
-
Zheng, Bo-Jian, primary, Chan, Kwok-Wah, additional, Im, Stanley, additional, Chua, Daniel, additional, Sham, Jonathan S.T., additional, Tin, Pui-Chi, additional, He, Zhi-Min, additional, and Ng, Mun-Hon, additional
- Published
- 2001
- Full Text
- View/download PDF
158. Recombinant ESAT-6-Like Proteins Provoke Protective Immune Responses against Invasive Staphylococcus aureusDisease in a Murine Model
- Author
-
Zhang, Bao Zhong, Hua, Yan Hong, Yu, Bin, Lau, Candy Choi Yi, Cai, Jian Piao, Zheng, Song Yue, Yam, Wing Cheong, Kao, Richard Yi Tsun, Sze, Kong Hung, Zheng, Bo Jian, Yuen, Kwok Yung, and Huang, Jian Dong
- Abstract
ABSTRACTStaphylococcus aureusis a common pathogen found in the community and in hospitals. Most notably, methicillin-resistant S. aureusis resistant to many antibiotics, which is a growing public health concern. The emergence of drug-resistant strains has prompted the search for alternative treatments, such as immunotherapeutic approaches. To date, most clinical trials of vaccines or of passive immunization against S. aureushave ended in failure. In this study, we investigated two ESAT-6-like proteins secreted by S. aureus, S. aureusEsxA (SaEsxA) and SaEsxB, as possible targets for a vaccine. Mice vaccinated with these purified proteins elicited high titers of anti-SaEsxA and anti-SaEsxB antibodies, but these antibodies could not prevent S. aureusinfection. On the other hand, recombinant SaEsxA (rSaEsxA) and rSaEsxB could induce Th1- and Th17-biased immune responses in mice. Mice immunized with rSaEsxA and rSaEsxB had significantly improved survival rates when challenged with S. aureuscompared with the controls. These findings indicate that SaEsxA and SaEsxB are two promising Th1 and Th17 candidate antigens which could be developed into multivalent and serotype-independent vaccines against S. aureusinfection.
- Published
- 2014
- Full Text
- View/download PDF
159. Rotavirus infection of the oropharynx and respiratory tract in young children
- Author
-
Zheng, Bo Jian, primary, Chang, Ru Xu, additional, Ma, Gui Zhang, additional, Xie, Ji Min, additional, Liu, Qi, additional, Liang, Xi Ruo, additional, and Ng, Mun Hon, additional
- Published
- 1991
- Full Text
- View/download PDF
160. Detection of serum neopterin for early assessment of dengue virus infection.
- Author
-
Chan, Cangel P.Y., Choi, Junet W.Y., Cao, Kai-Yuan, Wang, Ming, Gao, Yang, Zhou, Duan-Hua, Di, Biao, Xu, Hui-Fang, Leung, Man-Fai, Bergmann, Andreas, Lehmann, Matthias, Nie, Yong-Mei, Cautherley, George W.H., Fuchs, Dietmar, Renneberg, Reinhard, and Zheng, Bo-Jian
- Subjects
SERUM ,NEOPTERIN ,VIRUS diseases ,BLOOD plasma ,RESEARCH ,DENGUE ,MEASLES ,FEVER ,TIME ,FLAVIVIRUSES ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,COENZYMES ,COMPARATIVE studies ,INFLUENZA ,VIRAL antibodies - Abstract
Objective: Neopterin is generated and released in increased amounts by macrophages upon activation by interferon-gamma during Th1-type immune response. The potential usefulness of neopterin in early prognostic information of dengue virus infection was investigated.Methods: Neopterin concentrations were determined in serum samples from 110 dengue fever (DF) patients. The neopterin levels were compared with those in 50 measles and 40 influenza patients; 155 healthy blood donors served as controls.Results: In acute sera of DF patients mean neopterin concentration was 48.2 nmol/L, which was higher than that in patients with measles (mean: 36.3 nmol/L) and influenza (18.8 nmol/L) and in healthy controls (6.7 nmol/L; P<0.001). In the patients with confirmed DF, an early neopterin elevation was detected already at the first day after the onset of symptoms and rose to a maximum level of 54.3 nmol/L 4 days after the onset. Higher increase of neopterin level in DF patients was associated with longer duration of fever and thus predicted the clinical course of the disease.Conclusions: Neopterin concentrations were found significantly higher in DF patients compared with healthy controls and also with other viral infections (P<0.001) and may allow early assessment of the severity of DF. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
161. Anti-tumor effects of human peripheral γδ T cells in a mouse tumor model.
- Author
-
Zheng, Bo-Jian, Chan, Kwok-Wah, Im, Stanley, Chua, Daniel, Sham, Jonathan S.T., Tin, Pui-Chi, He, Zhi-Min, and Ng, Mun-Hon
- Published
- 2001
- Full Text
- View/download PDF
162. Prophylactic and Therapeutic Effects of Small Interfering Rna Targeting Sars-Coronavirus
- Author
-
Zheng, Bo-jian, Guan, Yi, Tang, Qingquan, Cheng, Du, Xie, Frank Y, He, Ming-Liang, Chan, Kwok-Wah, Wong, Kin-Ling, Lader, Eric, Woodle, Martin C, Lu, Patrick Y, Li, Baojian, and Zhong, Nanshan
- Abstract
Objectives To identify and characterize the siRNA duplexes that are effective for inhibition of SARS-CoV infection and replication in the non-human primate cells. This in vitro study will serve as the foundation for development of novel anti-SARS therapeutics.Methods 48 siRNA sequences were designed for targeting regions throughout entire SARS-CoV genome RNA including open-reading frames for several key proteins. Chemically synthesized siRNA duplexes were transfected into foetal rhesus kidney (FRhK-4) cells prior to or after SARS-CoV infection. The inhibitory effects of the siRNAs were evaluated for reductions of intracellular viral genome copy number and viral titres in the cell culture medium measured by Q-RT-PCR and CPE-based titration, respectively. Four siRNA duplexes were found to achieve potent inhibition of SARS-CoV infection and replication. A prolonged prophylactic effect of siRNA duplexes with up to 90% inhibition that lasted for at least 72 h was observed. Combination of active siRNA duplexes targeting different regions of the viral genome resulted in therapeutic activity of up to 80% inhibition.Conclusion Chemically synthesized siRNA duplexes targeting SARS-CoV genomic RNA are potent agents for inhibition of the viral infection and replication. The location effects of siRNAs were revealed at both genome sequence and open-reading frame levels. The rapid development of siRNA-based SARS-CoV inhibitors marked a novel approach for combating newly emergent infectious diseases.
- Published
- 2004
- Full Text
- View/download PDF
163. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
- Author
-
Yuan, Shuofeng, Chu, Hin, Zhao, Hanjun, Zhang, Ke, Singh, Kailash, Chow, Billy K.C., Kao, Richard Y.T., Zhou, Jie, and Zheng, Bo-Jian
- Subjects
- *
SMALL molecules , *INFLUENZA viruses , *ENZYME-linked immunosorbent assay , *FLUORESCENCE polarization immunoassay , *MEDICAL screening , *VIRAL replication - Abstract
Assembly of the heterotrimeric influenza virus polymerase complex from the individual subunits PB1, PA, and PB2 is a prerequisite for viral replication, in which the interaction between the C terminal of PA (PA C ) and the N-terminal of PB1 (PB1 N ) may be a desired target for antiviral development. In this study, we compared the feasibility of high throughput screening by enzyme-linked immunosorbent assay (ELISA) and fluorescence polarization assay. Among the two, ELISA was demonstrated to own broader dynamic range so that it was used for screening inhibitors that blocked PA C and PB1 N interaction. Several binding inhibitors of PA C -PB1 N were identified and subsequently tested for the antiviral efficacy. Apparently, 3-(2-chlorophenyl)-6-ethyl-7-methyl[1,2,4]triazolo[4,3-a]pyrimidin-5-ol, designated ANA-1, was found to be a strong inhibitor of viral polymerase activity and act as a potent antiviral agent against the infections of multiple subtypes of influenza A virus, including H1N1, H3N2, H5N1, H7N7, H7N9 and H9N2 subtypes, in cell cultures. Intranasal administration of ANA-1 protected mice from lethal challenge and reduced lung viral loads in H1N1 virus infected BALB/c mice. Docking analyses predicted that ANA-1 bound to an allosteric site of PA C , which might cause conformational changes thereby disrupting the PA C -PB1 N interaction. Overall, our study has identified a novel compound with potential to be developed as an anti-influenza drug. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
164. A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission.
- Author
-
Wu, Ruiping, Li, Xingxing, Leung, Ho-Chuen, Cao, Zhiliang, Qiu, Zonglin, Zhou, Yusen, Zheng, Bo-Jian, and He, Yuxian
- Subjects
- *
H5N1 Influenza , *IMMUNOGLOBULINS , *GENETIC mutation , *EPITOPES , *GENETICS , *ANTIGENS - Abstract
Highlights: [•] A novel mAb (HAb21) has been shown to possess a broadly neutralizing activity against all tested strains of H5N1. [•] HAb21 neutralizes diverse H5N1 variants with single or combination forms of mutations capable of airborne transmission. [•] HAb21 blocks the receptor-binding step by targeting a previously uncharacterized epitope at the tip of the HA head. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
165. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis.
- Author
-
Zhou, Jie, Chu, Hin, Li, Cun, Wong, Bosco Ho-Yin, Cheng, Zhong-Shan, Poon, Vincent Kwok-Man, Sun, Tianhao, Lau, Candy Choi-Yi, Wong, Kenneth Kak-Yuen, Chan, Jimmy Yu-Wai, Chan, Jasper Fuk-Woo, To, Kelvin Kai-Wang, Chan, Kwok-Hung, Zheng, Bo-Jian, and Yuen, Kwok-Yung
- Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) infection caused severe pneumonia and multiorgan dysfunction and had a higher crude fatality rate (around 50% vs. 10%) than SARS coronavirus (SARS-CoV) infection. To understand the pathogenesis, we studied viral replication, cytokine/chemokine response, and antigen presentation in MERS-CoV-infected human monocyte-derived macrophages (MDMs) versus SARS-CoV-infected MDMs. Only MERS-CoV can replicate in MDMs. Both viruses were unable to significantly stimulate the expression of antiviral cytokines (interferon α [IFN-α] and IFN-β) but induced comparable levels of tumor necrosis factor α and interleukin 6. Notably, MERS-CoV induced significantly higher expression levels of interleukin 12, IFN-γ, and chemokines (IP-10/CXCL-10, MCP-1/CCL-2, MIP-1α/CCL-3, RANTES/CCL-5, and interleukin 8) than SARS-CoV. The expression of major histocompatibility complex class I and costimulatory molecules were significantly higher in MERS-CoV-infected MDMs than in SARS-CoV-infected cells. MERS-CoV replication was validated by immunostaining of infected MDMs and ex vivo lung tissue. We conclusively showed that MERS-CoV can establish a productive infection in human macrophages. The aberrant induction of inflammatory cytokines/chemokines could be important in the disease pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
166. Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity
- Author
-
Zheng, Bo-Jian [Department of Microbiology, The University of Hong Kong (Hong Kong)]
- Published
- 2007
- Full Text
- View/download PDF
167. Leptin Mediates the Pathogenesis of Severe 2009 Pandemic Influenza A(H1N1) Infection Associated With Cytokine Dysregulation in Mice With Diet-Induced Obesity.
- Author
-
Zhang, Anna J. X., To, Kelvin K. W., Li, Can, Lau, Candy C. Y., Poon, Vincent K. M., Chan, Chris C. S., Zheng, Bo-Jian, Hung, Ivan F. N., Lam, Karen S. L., Xu, Aimin, and Yuen, Kwok-Yung
- Subjects
- *
LEPTIN , *H5N1 Influenza , *VIRUS diseases , *H1N1 influenza , *CYTOKINES , *LABORATORY mice , *DIET , *OBESITY - Abstract
Background. Obesity is associated with a high circulating leptin level and severe 2009 pandemic influenza A virus subtype H1N1 (A[H1N1]pdm09) infection. The mechanism for severe lung injury in obese patients and the specific treatment strategy remain elusive.Method. We studied the pathogenesis of A(H1N1)pdm09 infection in a mouse model of diet-induced obesity.Results. Obese mice had significantly higher initial pulmonary viral titer and mortality after challenge with A(H1N1)pdm09, compared with age-matched lean mice. Compared with lean mice, obese mice had heightened proinflammatory cytokine and chemokine levels and more severe pulmonary inflammatory damage. Furthermore, obese mice had a higher preexisting serum leptin level but a lower preexisting adiponectin level. Recombinant mouse leptin increased the interleukin 6 (IL-6) messenger RNA expression in mouse single-lung-cell preparations, mouse macrophages, and mouse lung epithelial cell lines infected with A(H1N1)pdm09. Administration of anti-leptin antibody improved the survival of infected obese mice, with associated reductions in pulmonary levels of the proinflammatory cytokines IL-6 and interleukin 1β but not the pulmonary viral titer.Conclusions. Our findings suggest that preexisting high levels of circulating leptin contribute to the development of severe lung injury by A(H1N1)pdm09 in mice with diet-induced obesity. The therapeutic strategy of leptin neutralization for the reduction of proinflammatory responses and pulmonary damage in obese patients warrants further investigations. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
168. Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on the Influenza Virus H5N1 Hemagglutinin.
- Author
-
Lanying Du, Lei Jin, Guangyu Zhao, Shihui Sun, Junfeng Li, Hong Yu, Ye Li, Zheng, Bo-Jian, Liddington, Robert C., Yusen Zhou, and Shibo Jiang
- Subjects
- *
H5N1 Influenza , *HEMAGGLUTININ , *IMMUNOGLOBULINS , *EPITOPES , *MAMMALS - Abstract
The unabated circulation of the highly pathogenic avian influenza A virus/H5N1 continues to be a serious threat to public health worldwide. Because of the high frequency of naturally occurring mutations, the emergence of H5N1 variants with high virulence has raised great concerns about the potential transmissibility of the virus in humans. Recent studies have shown that laboratory-mutated or reassortant H5N1 viruses could be efficiently transmitted among mammals, particularly ferrets, the best animal model for humans. Thus, it is critical to establish effective strategies to combat future H5N1 pandemics. In this study, we identified a broadly neutralizing monoclonal antibody (MAb), HA-7, that potently neutralized all tested strains of H5N1 covering clades 0, 1, 2.2, 2.3.4, and 2.3.2.1 and completely protected mice against lethal challenges of H5N1 viruses from clades 1 and 2.3.4. HA-7 specifically targeted the globular head of the H5N1 virus hemagglutinin (HA). Using electron microscopy technology with three-dimensional reconstruction (3D-EM), we discovered that HA-7 bound to a novel and highly conserved conformational epitope that was centered on residues 81 to 83 and 117 to 122 of HA1 (H5 numbering). We further demonstrated that HA-7 inhibited viral entry during postattachment events but not at the receptor-binding step, which is fully consistent with the 3D-EM result. Taken together, we propose that HA-7 could be humanized as an effective passive immunotherapeutic agent for antiviral stockpiling for future influenza pandemics caused by emerging unpredictable H5N1 strains. Our study also provides a sound foundation for the rational design of vaccines capable of inducing broad-spectrum immunity against H5N1. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
169. A Functional Variation in CD55 Increases the Severity of 2009 Pandemic H1N1 Influenza A Virus Infection.
- Author
-
Zhou, Jie, To, Kelvin Kai-Wang, Dong, Hui, Cheng, Zhong-Shan, Lau, Candy Choi-Yi, Poon, Vincent K. M., Fan, Yan-Hui, Song, You-Qiang, Tse, Herman, Chan, Kwok-Hung, Zheng, Bo-Jian, Zhao, Guo-Ping, and Yuen, Kwok-Yung
- Subjects
- *
H1N1 influenza , *HUMAN genetic variation , *PNEUMONIA , *SINGLE nucleotide polymorphisms , *GENE expression , *GENOMES , *EPITHELIAL cells - Abstract
Infection due to 2009 pandemic H1N1 influenza A virus (A[H1N1]pdm09) is commonly manifested as mild infection but occasionally as severe pneumonia. We hypothesized that host genetic variations may contribute to disease severity. An initially small-scale genome-wide association study guided the selection of CD55 single-nucleotide polymorphisms in 425 Chinese patients with severe (n = 177) or mild (n = 248) disease. Carriers of rs2564978 genotype T/T were significantly associated with severe infection (odds ratio, 1.75; P = .011) under a recessive model, after adjustment for clinical confounders. An allele-specific effect on CD55 expression was revealed and ascribed to a promoter indel variation, which was in complete linkage disequilibrium with rs2564978. The promoter variant with deletion exhibited significantly lower transcriptional activity. We further demonstrated that CD55 can protect respiratory epithelial cells from complement attack. Additionally, A(H1N1)pdm09 infection promoted CD55 expression. In conclusion, CD55 polymorphisms are associated with severe A(H1N1)pdm09 infection. CD55 may exert a substantial impact on the disease severity of A(H1N1)pdm09 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
170. SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.
- Author
-
Hu, Liang, Liu, Ming, Chen, Leilei, Chan, Tim Hon Man, Wang, Jian, Huo, Ke-ke, Zheng, Bo-Jian, Xie, Dan, and Guan, Xin-Yuan
- Subjects
- *
CARRIER proteins , *PROMOTERS (Genetics) , *UBIQUITIN ligases , *TUMOR suppressor genes , *LIVER cancer , *GENE expression , *MOLECULAR genetics , *CYTOPLASM , *GENETICS - Abstract
Pirh2 is a Ring-H2 domain containing E3 ubiquitin ligase that targets several important tumor suppressor genes for proteasomal degradation. Overexpression of Pirh2 is frequently detected in many clinical tumor tissues including hepatocellular carcinoma (HCC). However, the molecular mechanism of Pirh2 activation in tumorigenesis still remains poorly understood. In this study, we find a Pirh2-binding protein, SCYL1 binding protein 1 (SCYL1BP1), that can promote the ubiquitin-dependent degradation of Pirh2. SCYL1BP1 colocalized with Pirh2 in the cytoplasm and prevented its localization to the nucleus. Ectopic expression of SCYL1BP1 increased the expression of p53 and further inhibited the G1/S transition of HCC cell lines. Conversely, knock down of SCYL1BP1 restored the expression of Pirh2 and inhibited p53 at protein level. Functional assays found that reintroduction of SCYL1BP1 into HCC cell lines significantly inhibited cell proliferation, foci formation, colony formation in soft agar and tumor formation in nude mice, suggesting the strong tumor-suppressive function of SCYL1BP1 in HCC progression. Furthermore, SCYL1BP1 was found to be frequently downregulated in HCC clinical specimens compared to their paired non-tumor tissues by immunohistochemical staining. Taken together, our data suggested that the interaction of SCYL1BP1/Pirh2 could accelerate Pirh2 degradation through an ubiquitin-dependent pathway. SCYL1BP1 may function as an important tumor suppressor gene in HCC development.Abbreviations:CHXcycloheximideCo-IPco-immunoprecipitaionCULATRCommittee on the Use of Live Animals in Teaching and ResearchHA-UbHA-tagged ubiquitinHCChepatocellular carcinomaIgGimmunoglobulin GIHCimmunohistochemicalPLAGL2Pleomorphic Adenoma Gene Like 2qPCRquantitative real-time PCRRNAiRNA interferenceSCYL1BP1SCYL1 binding protein 1TIP60Tat-interactive protein of 60 kDaVec-LO2vector-transfected LO2XTT2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
171. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats.
- Author
-
Woo, Patrick C. Y., Lau, Susanna K. P., Wong, Beatrice H. L., Fan, Rachel Y. Y., Wong, Annette Y. P., Zhang, Anna J. X., Ying Wu, Choi, Garnet K. Y., Li, Kenneth S. M., Hui, Janet, Wang, Ming, Zheng, Bo-Jian, Chan, K. H., and Yuen, Kwok-Yung
- Subjects
- *
MORBILLIVIRUSES , *PARAMYXOVIRUSES , *INTERSTITIAL nephritis , *CATS as laboratory animals , *ELECTRON microscopy , *IMMUNOHISTOCHEMISTRY - Abstract
We describe the discovery and isolation of a paramyxovirus, feline morbillivirus (FmoPV), from domestic cat (Felis catus). FmoPV RNA was detected in 56 (12.3%) of 457 stray cats (53 urine, four rectal swabs, and one blood sample) by RT-PCR. Complete genome sequencing of three FmoPV strains showed genome sizes of 16,050 bases, the largest among morbilliviruses, because of unusually long 5' trailer sequences of 400 nt. FmoPV possesses identical gene contents (3'-N-P/V/C-M-F-H-L-5') and is phylogenetically clustered with other morbilliviruses. IgG against FmoPV N protein was positive in 49 sera (76.7%) of 56 RT-PCR-positive cats, but 78 (19.4%) of 401 RT-PCR-negative cats (P < 0.0001) by Western blot. FmoPV was isolated from CRFK feline kidney cells, causing cytopathic effects with cell rounding, detachment, lysis, and syncytia formation. FmoPV could also replicate in subsequent passages in primate Vero E6 cells. Infected cell lines exhibited finely granular and diffuse cytoplasmic fluorescence on immunostaining for FmoPV N protein. Electron microscopy showed enveloped virus with typical "herringbone" appearance of helical N in paramyxoviruses. Histological examination of necropsy tissues in two FmoPV-positive cats revealed interstitial inflammatory infiltrate and tubular degeneration/necrosis in kidneys, with decreased cauxin expression in degenerated tubular epithelial cells, compatible with tubulointerstitial nephritis (TIN). Immunohistochemical staining revealed FmoPV N protein-positive renal tubular cells and mononuclear cells in lymph nodes. A case-control study showed the presence of TIN in seven of 12 cats with FmoPV infection, but only two of 15 cats without FmoPV infection (P < 0.05), suggesting an association between FmoPV and TIN. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
172. A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy.
- Author
-
Yu, Bin, Yang, Mei, Wong, Ho, Watt, Rory, Song, Erwei, Zheng, Bo-Jian, Yuen, Kwok-Yung, and Huang, Jian-Dong
- Subjects
- *
SALMONELLA , *ANTIGENS , *TYPHOID vaccines , *NUCLEOTIDE sequence , *ESCHERICHIA coli , *CHROMOSOMES - Abstract
Live attenuated Salmonella enterica serovar Typhi Ty21a (Ty21a) is an important vaccine strain used in clinical studies for typhoid fever and as a vaccine vector for the expression of heterologous antigens. To facilitate the use of Ty21a in such studies, it is desirable to develop improved strategies that enable the stable chromosomal integration and expression of multiple heterologous antigens. The phage λ Red homologous recombination system has previously been used in various gram-negative bacteria species to mediate the accurate replacement of regions of chromosomal DNA with PCR-generated 'targeting cassettes' that contain flanking regions of shared homologous DNA sequence. However, the efficiency of λ Red-mediated recombineering in Ty21a is far lower than in Escherichia coli and other Salmonella typhimurium strains. Here, we describe an improved strategy for recombineering-based methods in Ty21a. Our reliable and efficient method involves the use of linear DNA-targeting cassettes that contain relatively long flanking 'arms' of sequence (ca. 1,000 bp) homologous to the chromosomal target. This enables multiple gene-targeting procedures to be performed on a single Ty21a chromosome in a straightforward, sequential manner. Using this strategy, we inserted three different influenza antigen expression cassettes as well as a green fluorescent protein gene reporter into four different loci on the Ty21a chromosome, with high efficiency and accuracy. Fluorescent microscopy and Western blotting analysis confirmed that strong inducible expression of all four heterologous genes could be achieved. In summary, we have developed an efficient, robust, and versatile method that may be used to construct recombinant Ty21a antigen-expressing strains. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
173. On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus.
- Author
-
Wang, Zai, Huang, Jian-Dong, Wong, Kin-Ling, Wang, Pei-Gang, Zhang, Hao-Jie, Tanner, Julian A., Spiga, Ottavia, Bernini, Andrea, Zheng, Bo-Jian, and Niccolai, Neri
- Subjects
- *
BIOCHEMICAL mechanism of action , *CORONAVIRUS diseases , *SARS disease , *ADAMANTANE , *DRUG activation , *MEMBRANE proteins , *GENETIC mutation , *DRUG resistance in microorganisms - Abstract
In a previous study, severe acute respiratory syndrome coronavirus (SARS-CoV) was cultured in the presence of bananin, an effective adamantane-related molecule with antiviral activity. In the present study, we show that all bananin-resistant variants exhibit mutations in helicase and membrane protein, although no evidence of bananin interference on their mutual interaction has been found. A structural analysis on protein sequence mutations found in SARS-CoV bananin-resistant variants was performed. The S259/L mutation of SARS-CoV helicase is always found in all the identified bananin-resistant variants, suggesting a primary role of this mutation site for bananin activity. From a structural analysis of SARS-CoV predicted helicase structure, S259 is found in a hydrophilic surface pocket, far from the enzyme active sites and outside the helicase dimer interface. The S/L substitution causes a pocket volume reduction that weakens the interaction between bananin and SARS-CoV mutated helicase, suggesting a possible mechanism for bananin antiviral activity. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
174. Identification of influenza A nucleoprotein as an antiviral target.
- Author
-
Kao, Richard Y., Yang, Dan, Lau, Lai-Shan, Tsui, Wayne H. W., Hu, Lihong, Dai, Jun, Chan, Mei-Po, Chan, Che-Man, Wang, Pui, Zheng, Bo-Jian, Sun, Jian, Huang, Jian-Dong, Madar, Jason, Chen, Guanhua, Chen, Honglin, Guan, Yi, and Yuen, Kwok-Yung
- Subjects
- *
INFLUENZA A virus , *INFLUENZA A virus, H5N1 subtype , *AVIAN influenza , *NUCLEOPROTEINS , *BIOCHEMICAL genetics , *LABORATORY mice - Abstract
Influenza A remains a significant public health challenge because of the emergence of antigenically shifted or highly virulent strains. Antiviral resistance to available drugs such as adamantanes or neuraminidase inhibitors has appeared rapidly, creating a need for new antiviral targets and new drugs for influenza virus infections. Using forward chemical genetics, we have identified influenza A nucleoprotein (NP) as a druggable target and found a small-molecule compound, nucleozin, that triggers the aggregation of NP and inhibits its nuclear accumulation. Nucleozin impeded influenza A virus replication in vitro with a nanomolar median effective concentration (EC50) and protected mice challenged with lethal doses of avian influenza A H5N1. Our results demonstrate that viral NP is a valid target for the development of small-molecule therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
175. Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3•TANK•TBK1/IKKϵ Complex.
- Author
-
Siu, Kam-Leung, Kok, Kin-Hang, Ng, Ming-Him James, Poon, Vincent K. M., Yuen, Kwok-Yung, Zheng, Bo-Jian, and Jin, Dong-Yan
- Subjects
- *
SARS disease , *CORONAVIRUSES , *INTERFERONS , *CONTACT inhibition , *GENETIC transcription , *VIRUS-induced enzymes , *PROTEINS , *RNA - Abstract
Severe acute respiratory syndrome (SARS) coronavirus is highly pathogenic in humans and evades innate immunity at multiple levels. It has evolved various strategies to counteract the production and action of type I interferons, which mobilize the front-line defense against viral infection. In this study we demonstrate that SARS coronavirus M protein inhibits gene transcription of type I interferons. M protein potently antagonizes the activation of interferon-stimulated response elementdependent transcription by double-stranded RNA, RIG-1, MDA5, TBK1, IKKϵ, and virus-induced signaling adaptor (VISA) but has no influence on the transcriptional activity of this element when IRF3 or IRF7 is overexpressed. M protein physically associates with RIG-1, TBK1, IKKϵ, and TRAF3 and likely sequesters some of them in membrane-associated cytoplasmic compartments. Consequently, the expression of M protein prevents the formation of TRAF3-TANKTBK1/IKKϵ complex and thereby inhibits TBK1/IKKϵ-dependent activation of IRF3/IRF7 transcription factors. Taken together, our findings reveal a new mechanism by which SARS coronavirus circumvents the production of type I interferons. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
176. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector
- Author
-
Zhang, Qiwei, Su, Xiaobo, Seto, Donald, Zheng, Bo-jian, Tian, Xingui, Sheng, Huiying, Li, Haitao, Wang, Youshao, and Zhou, Rong
- Subjects
- *
VIRAL replication , *ADENOVIRUSES , *VIRAL vaccines , *PLASMIDS , *POLYMERASE chain reaction , *RECOMBINANT viruses , *GENE therapy , *ESCHERICHIA coli - Abstract
Abstract: In southern China, as well as in neighboring Asian regions, human adenovirus type 3 (HAdV-3) outbreaks have become very prevalent in recent years. To address this problem regionally and globally, a recombinant virus has been constructed, containing a full-length infectious genomic clone of HAdV-3, to act as a vaccine. This was constructed by using a bacterial homologous recombination mechanism and was based on the cloning, manipulation and maintenance of the full-length adenovirus genome as a stable plasmid in E. coli. The resultant recombinant viral DNA was screened, identified and characterized by duplex PCR, Western blot, indirect immunofluorescence assay and electron microscopy. This putative vaccine strain was shown to be fully infectious in permissive cells, and no genome mutations were found in the recombinant plasmid. To demonstrate the utility of such a vaccine, a recombinant HAdV-3 plasmid expressing the reporter molecule eGFP was also constructed. This confirmed the recombinant protein expression capability. Mice immunized with this recombinant eGFP adenovirus by either intramuscular injection, intragastric or intranasal inoculation routes raised a significant antibody response to eGFP. Our results have provided a solid foundation for development of a recombinant live vaccine and potential more effective adenovirus vector-based delivery system for immune and gene therapy. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
177. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
- Author
-
Du, Lanying, Zhao, Guangyu, Lin, Yongping, Chan, Chris, He, Yuxian, Jiang, Shibo, Wu, Changyou, Jin, Dong-Yan, Yuen, Kwok-Yung, Zhou, Yusen, and Zheng, Bo-Jian
- Subjects
- *
PROTEINS , *EPITOPES , *RESPIRATORY organs , *SYNDROMES - Abstract
Summary: Development of vaccines against severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is crucial in the prevention of SARS reemergence. The receptor-binding domain (RBD) of SARS-CoV spike (S) protein is an important target in developing safe and effective SARS vaccines. Our previous study has demonstrated that vaccination with adeno-associated virus encoding RBD (RBD-rAAV) induces high titer of neutralizing antibodies. In this study, we further assessed the immune responses and protective effect of the immunization with RBD-rAAV prime/RBD-specific T cell peptide boost. Compared with the RBD-rAAV prime/boost vaccination, RBD-rAAV prime/RBD-peptide (RBD-Pep) boost induced similar levels of Th1 and neutralizing antibody responses that protected the vaccinated mice from subsequent SARS-CoV challenge, but stronger Th2 and CTL responses. No significant immune responses and protective effects were detected in mice vaccinated with RBD-Pep or blank AAV alone. Since T cell epitopes are highly conserved and boosting with peptides may induce the production of effector memory T cells, which may be effective against viruses with mutations in the neutralizing epitopes, our results suggest that the vaccination protocol used may be ideal for providing effective, broad and long-term protection against SARS-CoV infection. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
178. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
- Author
-
Du, Lanying, Zhao, Guangyu, He, Yuxian, Guo, Yan, Zheng, Bo-Jian, Jiang, Shibo, and Zhou, Yusen
- Subjects
- *
VACCINATION , *SARS disease , *PREVENTIVE medicine , *CRYOBIOLOGY - Abstract
Abstract: Development of effective vaccines against severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is still a priority in prevention of re-emergence of SARS. Our previous studies have shown that the receptor-binding domain (RBD) of SARS-CoV spike (S) protein elicits highly potent neutralizing antibody responses in the immunized animals. But it is unknown whether RBD can also induce protective immunity in an animal model, a key aspect for vaccine development. In this study, BALB/c mice were vaccinated intramuscularly (i.m.) with 10μg of RBD-Fc (RBD fused with human IgG1 Fc) and boosted twice at 3-week intervals and one more time at 12th month. Humoral immune responses of vaccinated mice were investigated for up to 12 months at a 1-month interval and the neutralizing titers of produced antibodies were reported at months 0, 3, 6 and 12 post-vaccination. Mice were challenged with the homologous strain of SARS-CoV 5 days after the last boost, and sacrificed 5 days after the challenge. Mouse lung tissues were collected for detection of viral load, virus replication and histopathological effects. Our results showed that RBD-Fc vaccination induced high titer of S-specific antibodies with long-term and potent SARS-CoV neutralizing activity. Four of five vaccinated mice were protected from subsequent SARS-CoV challenge because no significant virus replication, and no obvious histopathological changes were found in the lung tissues of the vaccinated mice challenged with SARS-CoV. Only one vaccinated mouse had mild alveolar damage in the lung tissues. In contrast, high copies of SARS-CoV RNA and virus replication were detected, and pathological changes were observed in the lung tissues of the control mice. In conclusion, our findings suggest that RBD, which can induce protective antibodies to SARS-CoV, may be further developed as a safe and effective SARS subunit vaccine. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
179. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection
- Author
-
Zhou, Jie, Lu, Liwei, Yuen, Man-Fung, Lam, Ting-Wa, Chung, Chi-Ping, Lam, Chun-Lit, Zhang, Bin, Wang, Song, Chen, Yu, Wu, Sharon HW, Poon, Vincent KM, Ng, Fai, Chan, Chris CS, Jiang, Shibo, Yuen, Kwok-Yung, and Zheng, Bo-Jian
- Subjects
- *
GENETIC polymorphisms , *HEPATITIS B , *HEPATITIS B virus , *GENE expression - Abstract
Background/Aims: Exposure to HBV leads to a distinct clinical course which is partially pertained to host genetic variability. We aimed to study polymorphisms of type I interferon receptor 1 (IFNAR1) promoter and their potential effects on chronic HBV infection. Methods: Polymorphisms of IFNAR1 promoter were identified in 320 chronic hepatitis B patients, 148 spontaneously recovered individuals, 148 healthy Chinese donors and 114 Caucasians. Their functional capability in driving reporter gene expression was analyzed. Results: Four polymorphic alleles were identified at loci −568, −408, −77 and −3. Association analysis revealed that carriers of alleles −568G, −408C and their related haplotype I were less susceptible to chronic HBV infection whereas those of alleles −568C, −408T and related haplotype III were significantly associated with higher risk to chronic hepatitis B (P <0.01). In a reporter-driven system, the promoter variants with alleles −408C and −3C could drive higher expression of the reporter gene than those with alleles −408T and −3T (P <0.01). Interestingly, an allele with 9 GT repeats at −77 that was rarely found in Chinese but prevalent in Caucasian exhibited the highest transcriptional ability. Conclusions: Our results showed that polymorphisms of IFNAR1 promoter may affect, at least in part, the outcomes of HBV infection. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
180. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
- Author
-
Yuan, Shuofeng, Chu, Hin, Singh, Kailash, Zhao, Hanjun, Zhang, Ke, Kao, Richard Y. T., Chow, Billy K. C., Zhou, Jie, and Zheng, Bo-Jian
- Published
- 2016
- Full Text
- View/download PDF
181. Retraction for Lau et al., "Coexistence of Different Genotypes in the Same Bat and Serological Characterization of Rousettus Bat Coronavirus HKU9 Belonging to a Novel Betacoronavirus Subgroup".
- Author
-
Lau SKP, Poon RWS, Wong BHL, Wang M, Huang Y, Xu H, Guo R, Li KSM, Gao K, Chan KH, Zheng BJ, Woo PCY, and Yuen KY
- Published
- 2022
- Full Text
- View/download PDF
182. Withdrawal: Leptin induces CD40 expression through the activation of Akt in murine dendritic cells.
- Author
-
Lam QLK, Zheng BJ, Jin DY, Cao X, and Lu L
- Published
- 2020
- Full Text
- View/download PDF
183. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou.
- Author
-
Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, Yuan L, Luo HJ, Zheng BJ, Yuen KY, Li MF, Cao KY, and Xu L
- Subjects
- China epidemiology, Coronavirus classification, Coronavirus pathogenicity, Humans, Coronavirus isolation & purification, Phylogeny, Respiratory Tract Infections epidemiology
- Abstract
Human coronavirus (HCoV) is one of the most common causes of respiratory tract infection throughout the world. To investigate the epidemiological and genetic variation of HCoV in Guangzhou, south China, we collected totally 13048 throat and nasal swab specimens from adults and children with fever and acute upper respiratory infection symptoms in Gunazhou, south China between July 2010 and June 2015, and the epidemiological features of HCoV and its species were studied. Specimens were screened for HCoV by real-time RT-PCR, and 7 other common respiratory viruses were tested simultaneously by PCR or real-time PCR. HCoV was detected in 294 cases (2.25%) of the 13048 samples, with most of them inpatients (251 cases, 85.4% of HCoV positive cases) and young children not in nursery (53.06%, 156 out of 294 HCoV positive cases). Four HCoVs, as OC43, 229E, NL63 and HKU1 were detected prevalent during 2010-2015 in Guangzhou, and among the HCoV positive cases, 60.20% were OC43, 16.67% were 229E, 14.97% were NL63 and 7.82% were HKU1. The month distribution showed that totally HCoV was prevalent in winter, but differences existed in different species. The 5 year distribution of HCoV showed a peak-valley distribution trend, with the detection rate higher in 2011 and 2013 whereas lower in 2010, 2012 and 2014. The age distribution revealed that children (especially those <3 years old) and old people (>50 years) were both high risk groups to be infected by HCoV. Of the 294 HCoV positive patients, 34.69% (101 cases) were co-infected by other common respiratory viruses, and influenza virus was the most common co-infecting virus (30/101, 29.70%). Fifteen HCoV-OC43 positive samples of 2013-2014 were selected for S gene sequencing and phylogenetic analysis, and the results showed that the 15 strains could be divided into 2 clusters in the phylogenetic tree, 12 strains of which formed a separate cluster that was closer to genotype G found in Malaysia. It was revealed for the first time that genotype B and genotype G of HCoV-OC43 co-circulated and the newly defined genotype G was epidemic as a dominant genotype during 2013-2014 in Guanzhou, south China.
- Published
- 2018
- Full Text
- View/download PDF
184. Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice.
- Author
-
Ye ZW, Yuan S, Poon KM, Wen L, Yang D, Sun Z, Li C, Hu M, Shuai H, Zhou J, Zhang MY, Zheng BJ, Chu H, and Yuen KY
- Abstract
Engaging the antibody-dependent cell-mediated cytotoxicity (ADCC) for killing of virus-infected cells and secretion of antiviral cytokines and chemokines was incorporated as one of the important features in the design of universal influenza vaccines. However, investigation of the ADCC epitopes on the highly immunogenic influenza hemagglutinin (HA) head region has been rarely reported. In this study, we determined the ADCC and antiviral activities of two putative ADCC epitopes, designated E1 and E2, on the HA head of a pandemic H1N1 influenza virus in vitro and in a lethal mouse model. Our data demonstrated that sera from the E1-vaccinated mice could induce high ADCC activities. Importantly, the induction of ADCC response modestly decreased viral load in the lungs of H1N1-infected mice. However, the elevated ADCC significantly increased mouse alveolar damage and mortality than that of the PBS-vaccinated group ( P < 0.0001). The phenotype was potentially due to an exaggerated inflammatory cell infiltration triggered by ADCC, as an upregulated release of cytotoxic granules (perforin) was observed in the lung tissue of E1-vaccinated mice after H1N1 influenza virus challenge. Overall, our data suggested that ADCC elicited by certain domains of HA head region might have a detrimental rather than protective effect during influenza virus infection. Thus, future design of universal influenza vaccine shall strike a balance between the induction of protective immunity and potential side effects of ADCC.
- Published
- 2017
- Full Text
- View/download PDF
185. PAN substitutions A37S, A37S/I61T and A37S/V63I attenuate the replication of H7N7 influenza A virus by impairing the polymerase and endonuclease activities.
- Author
-
Hu M, Yuan S, Ye ZW, Singh K, Li C, Shuai H, Fai N, Chow BKC, Chu H, and Zheng BJ
- Subjects
- Amino Acid Substitution, Animals, Birds, Dogs, Influenza A Virus, H7N7 Subtype genetics, Influenza A Virus, H7N7 Subtype growth & development, Madin Darby Canine Kidney Cells, Protein Domains, RNA, Viral genetics, RNA-Dependent RNA Polymerase genetics, Viral Proteins genetics, Virulence genetics, Virulence Factors genetics, Virus Replication genetics, Influenza A Virus, H7N7 Subtype pathogenicity, Influenza in Birds virology, RNA-Dependent RNA Polymerase metabolism, Viral Proteins metabolism, Virulence Factors metabolism
- Abstract
Substitutions in the PA N-terminus (PAN) of influenza A viruses are associated with viral pathogenicity. During our previous study, which identified PAN-V63I and -A37S/I61T/V63I/V100A substitutions as virulence determinants, we observed a severe decrease in virus growth and transcription/replication capacity posed by PAN-A37S/V100A substitution. To further delineate the significance of substitutions at these positions, we generated mutant H7N7 viruses bearing the substitutions PAN-A37S, -A37S/I61T, -A37S/V63I, -V100A, -I61T/V100A and -V63I/V100A by reverse genetics. Our results showed that all mutant viruses except PAN-V100A showed a significantly reduced growth capability in infected cells. At the same time, the PAN-A37S, -A37S/I61T and -A37S/V63I mutant viruses displayed decreased viral transcription and replication by diminishing virus RNA synthesis activity. Biochemical assays indicated that the substitutions PAN-A37S, -A37S/I61T and -A37S/V63I suppressed the polymerase and endonuclease activities when compared with those of the wild-type. Together, our results demonstrated that the PAN-A37S, -A37S/I61T and -A37S/V63I substitutions contributed to a decreased pathogenicity of avian H7N7 influenza A virus.
- Published
- 2017
- Full Text
- View/download PDF
186. Identification and genomic characterization of a novel rat bocavirus from brown rats in China.
- Author
-
Lau SK, Yeung HC, Li KS, Lam CS, Cai JP, Yuen MC, Wang M, Zheng BJ, Woo PC, and Yuen KY
- Subjects
- Animals, China, DNA, Viral genetics, RNA Splice Sites genetics, Bocavirus genetics, Genome, Viral genetics, Parvoviridae Infections veterinary, Parvoviridae Infections virology, Rats virology
- Abstract
Despite recent discoveries of novel animal bocaparvoviruses, current understandings on the diversity and evolution of bocaparvoviruses are still limited. We report the identification and genome characterization of a novel bocaparvovirus, rat bocaparvovirus (RBoV), in brown rats (Rattus norvegicus) in China. RBoV was detected in 11.5%, 2.4%, 16.2% and 0.3% of alimentary, respiratory, spleen and kidney samples respectively, of 636 brown rats by PCR, but not in samples of other rodent species, suggesting that brown rats are the primary reservoir of RBoV. Six RBoV genomes sequenced from three brown rats revealed the presence of three ORFs, characteristic of bocaparvoviruses. Phylogenetic analysis showed that RBoV was distantly related to other bocaparvoviruses, forming a distinct cluster within the genus, with ≤55.5% nucleotide identities to the genome of ungulate bocaparvovirus 3, supporting its classification as a novel bocaparvovirus species. RBoV possessed a putative second exon encoding the C-terminal region of NS1 and conserved RNA splicing signals, similar to human bocaparvoviruses and canine bocaparvovirus. In contrast to human, feline and canine bocaparvoviruses which demonstrates inter/intra-host viral diversity, partial VP1/VP2 sequences of 49 RBoV strains demonstrated little inter-host genetic diversity, suggesting a single genetic group. Although the pathogenicity of RBoV remains to be determined, its presence in different host tissues suggests wide tissue tropism. RBoV represents the first bocaparvovirus in rodents with genome sequenced, which extends our knowledge on the host range of bocaparvoviruses. Further studies are required to better understand the epidemiology, genetic diversity and pathogenicity of bocaparvoviruses in different rodent populations., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
187. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
- Author
-
Yuan S, Chu H, Ye J, Singh K, Ye Z, Zhao H, Kao RY, Chow BK, Zhou J, and Zheng BJ
- Subjects
- Animals, Antiviral Agents administration & dosage, Antiviral Agents isolation & purification, Antiviral Agents therapeutic use, Binding Sites, Cell Line, Influenza A Virus, H1N1 Subtype drug effects, Influenza A Virus, H5N1 Subtype drug effects, Influenza A Virus, H7N7 Subtype drug effects, Influenza A Virus, H7N9 Subtype drug effects, Influenza A Virus, H9N2 Subtype drug effects, Influenza A virus enzymology, Mice, Molecular Docking Simulation, Protein Binding, Protein Interaction Domains and Motifs, Protein Interaction Mapping, RNA-Dependent RNA Polymerase chemistry, RNA-Dependent RNA Polymerase metabolism, Small Molecule Libraries, Viral Proteins chemistry, Viral Proteins metabolism, Virus Replication drug effects, Antiviral Agents pharmacology, Influenza A virus chemistry, Influenza A virus drug effects, RNA-Dependent RNA Polymerase antagonists & inhibitors, Viral Proteins antagonists & inhibitors
- Abstract
The PB1 C-terminal domain and PB2 N-terminal domain interaction of the influenza A polymerase, which modulates the assembly of PB1 and PB2 subunits, may serve as a valuable target for the development of novel anti-influenza therapeutics. In this study, we performed a systematic screening of a chemical library, followed by the antiviral evaluation of primary hits and their analogues. Eventually, a novel small-molecule compound PP7 that abrogated the PB1-PB2 association and impaired viral polymerase activity was identified. PP7 exhibited antiviral activities against influenza virus subtypes A (H1N1)pdm09, A(H7N9) and A(H9N2) in cell cultures and partially protected mice against lethal challenge of mouse-adapted influenza A (H1N1)pdm09 virus. Surprisingly, a panel of other subtypes of influenza virus, including A(H5N1) and A(H7N7), showed various degrees of resistance to the compound. Biochemical studies revealed a similar pattern of resistance on the impairment of polymerase activity. Molecular docking analyses suggested a PP7-binding site that appeared to be completely conserved among the subtypes of the virus mentioned above. Thus, we propose that alternative/additional binding site (s) may exist for the regulation of PB1-PB2 subunits assembly of influenza A virus., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
188. Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways.
- Author
-
Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, Yang D, Wang D, Lee AC, Li C, Yeung ML, Cai JP, Chan IH, Ho WK, To KK, Zheng BJ, Yao Y, Qin C, and Yuen KY
- Subjects
- Animals, Antibodies, Viral, Callithrix, Cells, Cultured, Dipeptidyl Peptidase 4 genetics, Dipeptidyl Peptidase 4 metabolism, Gene Expression Regulation, Humans, Palatine Tonsil cytology, Severe acute respiratory syndrome-related coronavirus physiology, Spleen cytology, T-Lymphocytes physiology, Apoptosis physiology, Middle East Respiratory Syndrome Coronavirus physiology, T-Lymphocytes virology
- Abstract
Middle East respiratory syndrome (MERS) is associated with a mortality rate of >35%. We previously showed that MERS coronavirus (MERS-CoV) could infect human macrophages and dendritic cells and induce cytokine dysregulation. Here, we further investigated the interplay between human primary T cells and MERS-CoV in disease pathogenesis. Importantly, our results suggested that MERS-CoV efficiently infected T cells from the peripheral blood and from human lymphoid organs, including the spleen and the tonsil. We further demonstrated that MERS-CoV infection induced apoptosis in T cells, which involved the activation of both the extrinsic and intrinsic apoptosis pathways. Remarkably, immunostaining of spleen sections from MERS-CoV-infected common marmosets demonstrated the presence of viral nucleoprotein in their CD3(+) T cells. Overall, our results suggested that the unusual capacity of MERS-CoV to infect T cells and induce apoptosis might partly contribute to the high pathogenicity of the virus., (© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
189. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2.
- Author
-
Yeung ML, Yao Y, Jia L, Chan JF, Chan KH, Cheung KF, Chen H, Poon VK, Tsang AK, To KK, Yiu MK, Teng JL, Chu H, Zhou J, Zhang Q, Deng W, Lau SK, Lau JY, Woo PC, Chan TM, Yung S, Zheng BJ, Jin DY, Mathieson PW, Qin C, and Yuen KY
- Subjects
- Animals, Callithrix, Cytopathogenic Effect, Viral, Disease Models, Animal, Host-Pathogen Interactions, Humans, Organ Culture Techniques, Apoptosis, Coronavirus Infections pathology, Fibroblast Growth Factor 2 metabolism, Kidney pathology, Lung pathology, Middle East Respiratory Syndrome Coronavirus pathogenicity, Smad7 Protein metabolism
- Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) causes sporadic zoonotic disease and healthcare-associated outbreaks in human. MERS is often complicated by acute respiratory distress syndrome (ARDS) and multi-organ failure(1,2). The high incidence of renal failure in MERS is a unique clinical feature not often found in other human coronavirus infections(3,4). Whether MERS-CoV infects the kidney and how it triggers renal failure are not understood(5,6). Here, we demonstrated renal infection and apoptotic induction by MERS-CoV in human ex vivo organ culture and a nonhuman primate model. High-throughput analysis revealed that the cellular genes most significantly perturbed by MERS-CoV have previously been implicated in renal diseases. Furthermore, MERS-CoV induced apoptosis through upregulation of Smad7 and fibroblast growth factor 2 (FGF2) expression in both kidney and lung cells. Conversely, knockdown of Smad7 effectively inhibited MERS-CoV replication and protected cells from virus-induced cytopathic effects. We further demonstrated that hyperexpression of Smad7 or FGF2 induced a strong apoptotic response in kidney cells. Common marmosets infected by MERS-CoV developed ARDS and disseminated infection in kidneys and other organs. Smad7 and FGF2 expression were elevated in the lungs and kidneys of the infected animals. Our results provide insights into the pathogenesis of MERS-CoV and host targets for treatment.
- Published
- 2016
- Full Text
- View/download PDF
190. Combined prokaryotic-eukaryotic delivery and expression of therapeutic factors through a primed autocatalytic positive-feedback loop.
- Author
-
Shi L, Yu B, Cai CH, Huang W, Zheng BJ, Smith DK, and Huang JD
- Subjects
- Animals, Cell Cycle Proteins genetics, Cell Line, Tumor, Diphtheria Toxin genetics, Feedback, Physiological, Female, Genetic Vectors, Humans, Mice, Mice, Inbred BALB C, Mice, Nude, Neoplasms therapy, Peptide Fragments genetics, Plasmids, Protein Serine-Threonine Kinases genetics, Proto-Oncogene Proteins genetics, RNA Interference, RNA, Small Interfering genetics, Polo-Like Kinase 1, Genetic Therapy methods, Salmonella typhimurium genetics
- Abstract
Progress in bacterial therapy for cancer and infectious diseases is hampered by the absence of safe and efficient vectors. Sustained delivery and high gene expression levels are critical for the therapeutic efficacy. Here we developed a Salmonella typhimrium strain to maintain and safely deliver a plasmid vector to target tissues. This vector is designed to allow dual transcription of therapeutic factors, such as cytotoxic proteins, short hairpin RNAs or combinations, in the nucleus or cytoplasm of eukaryotic cells, with this expression sustained by an autocatalytic positive-feedback loop. Mechanisms to prime the system and maintain the plasmid in the bacterium are also provided. Synergistic effects of attenuated Salmonella and our inter-kingdom system allow the precise expression of Diphtheria toxin A chain (DTA) gene in tumor microenvironment and eradicate large established tumors in immunocompetent animals. In the experiments reported here, 26% of mice (n=5/19) with aggressive tumors were cured and the others all survived until the end of the experiment. We also demonstrated that ST4 packaged with shRNA-encoding plasmids has sustained knockdown effects in nude mice bearing human MDA-MB-231 xenografts. Three weeks after injection of 5×10(6) ST4/pIKT-shPlk, PLK1 transcript levels in tumors were 62.5±18.6% lower than the vector control group (P=0.015). The presence of PLK1 5' RACE-PCR cleavage products confirmed a sustained RNAi-mediated mechanism of action. This innovative technology provides an effective and versatile vehicle for efficient inter-kingdom gene delivery that can be applied to cancer therapy and other purposes., (Copyright © 2015. Published by Elsevier B.V.)
- Published
- 2016
- Full Text
- View/download PDF
191. Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza.
- Author
-
Cheng Z, Zhou J, To KK, Chu H, Li C, Wang D, Yang D, Zheng S, Hao K, Bossé Y, Obeidat M, Brandsma CA, Song YQ, Chen Y, Zheng BJ, Li L, and Yuen KY
- Subjects
- Adult, Aged, Cohort Studies, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, Humans, Lung virology, Male, Middle Aged, Quantitative Trait Loci, Severity of Illness Index, Influenza A Virus, H1N1 Subtype genetics, Influenza A Virus, H7N9 Subtype genetics, Influenza, Human virology, Polymorphism, Single Nucleotide, Serine Endopeptidases genetics
- Abstract
The genetic predisposition to severe A(H1N1)2009 (A[H1N1]pdm09) influenza was evaluated in 409 patients, including 162 cases with severe infection and 247 controls with mild infection. We prioritized candidate variants based on the result of a pilot genome-wide association study and a lung expression quantitative trait locus data set. The GG genotype of rs2070788, a higher-expression variant of TMPRSS2, was a risk variant (odds ratio, 2.11; 95% confidence interval, 1.18-3.77; P = .01) to severe A(H1N1)pdm09 influenza. A potentially functional single-nucleotide polymorphism, rs383510, accommodated in a putative regulatory region was identified to tag rs2070788. Luciferase assay results showed the putative regulatory region was a functional element, in which rs383510 regulated TMPRSS2 expression in a genotype-specific manner. Notably, rs2070788 and rs383510 were significantly associated with the susceptibility to A(H7N9) influenza in 102 patients with A(H7N9) influenza and 106 healthy controls. Therefore, we demonstrate that genetic variants with higher TMPRSS2 expression confer higher risk to severe A(H1N1)pdm09 influenza. The same variants also increase susceptibility to human A(H7N9) influenza., (© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
192. A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs.
- Author
-
Zhang XM, Wu H, Zhang Q, Lau TC, Chu H, Chen ZW, Jin DY, and Zheng BJ
- Subjects
- Humans, Microbial Sensitivity Tests, Models, Molecular, Mutant Proteins genetics, Mutant Proteins metabolism, Protein Conformation, Reverse Transcription, Drug Resistance, Viral, HIV Reverse Transcriptase genetics, HIV Reverse Transcriptase metabolism, HIV-1 drug effects, HIV-1 enzymology, Mutation, Missense, Reverse Transcriptase Inhibitors pharmacology
- Abstract
Objectives: Growing evidence suggests that mutations in the connection domain of the HIV-1 reverse transcriptase (RT) can contribute to viral resistance to RT inhibitors. This work was designed to determine the effects of a novel mutation, D404N, in the connection subdomain of RT of HIV-1 CRF08_BC subtype on drug resistance, viral replication capacity (RC) and RT activity., Methods: Mutation D404N, alone or together with the other reported mutations, was introduced into an HIV-1 CRF08_BC subtype infectious clone by site-directed mutagenesis. Viral susceptibility to nine RT inhibitors, viral RC and the DNA polymerase activity of viral RT of the constructed virus mutants were investigated. A modelling study using the server SWISS-MODEL was conducted to explore the possible structure-related drug resistance mechanism of the mutation D404N., Results: Single mutations D404N and H221Y conferred low-level resistance to nevirapine, efavirenz, rilpivirine and zidovudine. Double mutations Y181C/D404N and Y181C/H221Y significantly reduced susceptibility to NNRTIs. The most pronounced resistance to NNRTIs was observed with the triple mutation Y181C/D404N/H221Y. Virus containing D404N as the only mutation displayed ∼50% RC compared with the WT virus. The modelling study suggested that the D404N mutation might abolish the hydrogen bonds between residues 404 and K30 in p51 or K431 in p66, leading to impaired RT subunit structure and enhanced drug resistance., Conclusions: These results indicate that D404N is a novel NNRTI-associated mutation in the HIV-1 subtype CRF08_BC and provides information valuable for the monitoring of clinical RTI resistance., (© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
193. Adenovirus-based vaccines against avian-origin H5N1 influenza viruses.
- Author
-
He B, Zheng BJ, Wang Q, Du L, Jiang S, and Lu L
- Subjects
- Animals, Birds, China epidemiology, Communicable Disease Control, Humans, Influenza Vaccines administration & dosage, Influenza, Human epidemiology, Influenza, Human transmission, Influenza, Human virology, Adenoviridae immunology, Influenza A Virus, H5N1 Subtype immunology, Influenza Vaccines immunology, Influenza in Birds virology, Influenza, Human prevention & control
- Abstract
Since 1997, human infection with avian H5N1, having about 60% mortality, has posed a threat to public health. In this review, we describe the epidemiology of H5N1 transmission, advantages and disadvantages of different influenza vaccine types, and characteristics of adenovirus, finally summarizing advances in adenovirus-based H5N1 systemic and mucosal vaccines., (Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
194. Advancements in the development of subunit influenza vaccines.
- Author
-
Zhang N, Zheng BJ, Lu L, Zhou Y, Jiang S, and Du L
- Subjects
- Animals, Humans, Influenza A virus immunology, Influenza A virus pathogenicity, Influenza A virus physiology, Influenza Vaccines immunology, Influenza Vaccines therapeutic use, Vaccines, Subunit genetics, Vaccines, Subunit immunology, Influenza Vaccines genetics
- Abstract
The ongoing threat of influenza epidemics and pandemics has emphasized the importance of developing safe and effective vaccines against infections from divergent influenza viruses. In this review, we first introduce the structure and life cycle of influenza A viruses, describing major influenza A virus-caused pandemics. We then compare different types of influenza vaccines and discuss current advancements in the development of subunit influenza vaccines, particularly those based on nucleoprotein (NP), extracellular domain of matrix protein 2 (M2e) and hemagglutinin (HA) proteins. We also illustrate potential strategies for improving the efficacy of subunit influenza vaccines., (Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
195. Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.
- Author
-
Zheng SY, Yu B, Zhang K, Chen M, Hua YH, Yuan S, Watt RM, Zheng BJ, Yuen KY, and Huang JD
- Subjects
- Administration, Oral, Animals, Anti-Bacterial Agents pharmacology, Female, Green Fluorescent Proteins metabolism, Hemagglutination Inhibition Tests, Immunity, Humoral drug effects, Immunity, Humoral immunology, Influenza A Virus, H5N1 Subtype immunology, Interferon-gamma immunology, Mice, Mice, Inbred BALB C, Microbial Viability drug effects, Plasmids genetics, Salmonella Infections, Animal immunology, Salmonella Infections, Animal microbiology, Salmonella Vaccines administration & dosage, Salmonella typhimurium cytology, Salmonella typhimurium drug effects, Salmonella typhimurium growth & development, Antigens, Bacterial immunology, Hemagglutinin Glycoproteins, Influenza Virus immunology, Recombination, Genetic genetics, Salmonella Vaccines immunology, Salmonella typhimurium immunology
- Abstract
Background: Despite the development of various systems to generate live recombinant Salmonella Typhimurium vaccine strains, little work has been performed to systematically evaluate and compare their relative immunogenicity. Such information would provide invaluable guidance for the future rational design of live recombinant Salmonella oral vaccines., Result: To compare vaccine strains encoded with different antigen delivery and expression strategies, a series of recombinant Salmonella Typhimurium strains were constructed that expressed either the enhanced green fluorescent protein (EGFP) or a fragment of the hemagglutinin (HA) protein from the H5N1 influenza virus, as model antigens. The antigens were expressed from the chromosome, from high or low-copy plasmids, or encoded on a eukaryotic expression plasmid. Antigens were targeted for expression in either the cytoplasm or the outer membrane. Combinations of strategies were employed to evaluate the efficacy of combined delivery/expression approaches. After investigating in vitro and in vivo antigen expression, growth and infection abilities; the immunogenicity of the constructed recombinant Salmonella strains was evaluated in mice. Using the soluble model antigen EGFP, our results indicated that vaccine strains with high and stable antigen expression exhibited high B cell responses, whilst eukaryotic expression or colonization with good construct stability was critical for T cell responses. For the insoluble model antigen HA, an outer membrane expression strategy induced better B cell and T cell responses than a cytoplasmic strategy. Most notably, the combination of two different expression strategies did not increase the immune response elicited., Conclusion: Through systematically evaluating and comparing the immunogenicity of the constructed recombinant Salmonella strains in mice, we identified their respective advantages and deleterious or synergistic effects. Different construction strategies were optimally-required for soluble versus insoluble forms of the protein antigens. If an antigen, such as EGFP, is soluble and expressed at high levels, a low-copy plasmid-cytoplasmic expression strategy is recommended; since it provokes the highest B cell responses and also induces good T cell responses. If a T cell response is preferred, a eukaryotic expression plasmid or a chromosome-based, cytoplasmic-expression strategy is more effective. For insoluble antigens such as HA, an outer membrane expression strategy is recommended.
- Published
- 2012
- Full Text
- View/download PDF
196. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
- Author
-
Chan TH, Chen L, Liu M, Hu L, Zheng BJ, Poon VK, Huang P, Yuan YF, Huang JD, Yang J, Tsao GS, and Guan XY
- Subjects
- CDC2 Protein Kinase metabolism, Cell Division, Cell Transformation, Neoplastic, Disease Progression, Electrophoresis, Gel, Two-Dimensional, G2 Phase, Hep G2 Cells, Humans, Tumor Protein, Translationally-Controlled 1, Up-Regulation, cdc25 Phosphatases metabolism, Biomarkers, Tumor metabolism, Carcinoma, Hepatocellular metabolism, Chromosome Segregation, DNA Helicases metabolism, DNA-Binding Proteins metabolism, Liver Neoplasms metabolism
- Abstract
Unlabelled: Emerging evidence implicates the chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) as a specific oncogene in human hepatocellular carcinoma (HCC). To better understand the molecular mechanisms underlying HCC cases carrying CHD1L amplification (>50% HCCs), we identified a CHD1L target, translationally controlled tumor protein (TCTP), and investigated its role in HCC progression. Here, we report that CHD1L protein directly binds to the promoter region (nt -733 to -1,027) of TCTP and activates TCTP transcription. Overexpression of TCTP was detected in 40.7% of human HCC samples analyzed and positively correlated with CHD1L overexpression. Clinically, overexpression of TCTP was significantly associated with the advanced tumor stage (P = 0.037) and overall survival time of HCC patients (P = 0.034). In multivariate analyses, TCTP was determined to be an independent marker associated with poor prognostic outcomes. In vitro and in vivo functional studies in mice showed that TCTP has tumorigenic abilities, and overexpression of TCTP induced by CHD1L contributed to the mitotic defects of tumor cells. Further mechanistic studies demonstrated that TCTP promoted the ubiquitin-proteasome degradation of Cdc25C during mitotic progression, which caused the failure in the dephosphorylation of Cdk1 on Tyr15 and decreased Cdk1 activity. As a consequence, the sudden drop of Cdk1 activity in mitosis induced a faster mitotic exit and chromosome missegregation, which led to chromosomal instability. The depletion experiment proved that the tumorigenicity of TCTP was linked to its role in mitotic defects., Conclusion: Collectively, we reveal a novel molecular pathway (CHD1L/TCTP/Cdc25C/Cdk1), which causes the malignant transformation of hepatocytes with the phenotypes of accelerated mitotic progression and the production of aneuploidy., (Copyright © 2011 American Association for the Study of Liver Diseases.)
- Published
- 2012
- Full Text
- View/download PDF
197. A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection.
- Author
-
Wang X, Chan CC, Yang M, Deng J, Poon VK, Leung VH, Ko KH, Zhou J, Yuen KY, Zheng BJ, and Lu L
- Subjects
- Animals, B-Lymphocytes cytology, B-Lymphocytes metabolism, Cell Movement immunology, Chemokine CXCL13 biosynthesis, Chemokine CXCL13 immunology, Down-Regulation, Female, Flow Cytometry, Humans, Influenza A Virus, H5N1 Subtype pathogenicity, Influenza, Human immunology, Influenza, Human pathology, Influenza, Human virology, Interleukin-17 deficiency, Interleukin-17 genetics, Lung immunology, Lung pathology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Orthomyxoviridae Infections mortality, Orthomyxoviridae Infections pathology, Orthomyxoviridae Infections virology, Receptors, CXCR5 biosynthesis, Receptors, CXCR5 immunology, Survival Rate, Weight Loss, B-Lymphocytes immunology, Gene Deletion, Influenza A Virus, H5N1 Subtype immunology, Interleukin-17 immunology, Lung virology, Orthomyxoviridae Infections immunology
- Abstract
Interleukin-17 (IL-17), a member of the IL-17 cytokine family, plays a crucial role in mediating the immune response against extracellular bacteria and fungi in the lung. Although there is increasing evidence that IL-17 is involved in protective immunity against H1 and H3 influenza virus infections, little is known about the role of IL-17 in the highly pathogenic H5N1 influenza virus infection. In this study, we show that H5N1-infected IL-17 knockout (KO) mice exhibit markedly increased weight loss, more pronounced lung immunopathology and significantly reduced survival rates as compared with infected wild-type controls. Moreover, the frequency of B cells in the lung were substantially decreased in IL-17 KO mice after virus infection, which correlated with reduced CXCR5 expression in B cells and decreased CXCL13 production in the lung tissue of IL-17 KO mice. Consistent with this observation, B cells from IL-17 KO mice exhibited a significant reduction in chemokine-mediated migration in culture. Taken together, these findings demonstrate a critical role for IL-17 in mediating the recruitment of B cells to the site of pulmonary influenza virus infection in mice.
- Published
- 2011
- Full Text
- View/download PDF
198. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
- Author
-
Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, and Guan XY
- Subjects
- Adenoviridae genetics, Adult, Aged, Animals, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Apoptosis drug effects, Carcinoma, Hepatocellular drug therapy, DNA Helicases genetics, DNA Helicases physiology, DNA-Binding Proteins genetics, DNA-Binding Proteins physiology, Doxorubicin pharmacology, Drug Resistance, Neoplasm, Female, Fluorouracil pharmacology, Fluorouracil therapeutic use, Gene Silencing, Genetic Therapy methods, Genetic Vectors, Humans, Liver Neoplasms drug therapy, Male, Mice, Mice, Nude, Middle Aged, Neoplasm Proteins genetics, Neoplasm Proteins physiology, Prognosis, Retrospective Studies, Signal Transduction, Treatment Outcome, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Young Adult, Biomarkers, Tumor metabolism, Carcinoma, Hepatocellular metabolism, DNA Helicases metabolism, DNA-Binding Proteins metabolism, Liver Neoplasms metabolism, Neoplasm Proteins metabolism
- Abstract
Background: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified oncogene responsible for 1q21 amplification. This study aims to investigate the role of CHD1L in predicting prognosis and chemotherapy response of patients with HCC, its chemoresistant mechanism and whether virus-mediated CHD1L silencing has therapeutic potentials for HCC treatment., Methods: The clinical significance of CHD1L in a cohort of 109 HCC cases including 50 cases who received transarterial chemoembolisation treatment was assessed by clinical correlation and Kaplan-Meier analyses. A CHD1L-overexpressing cell model was generated and the mechanism of chemoresistance involving CHD1L was investigated. An adenovirus-mediated silencing method was used to knockdown CHD1L, and its effects on tumorigenicity and chemoresistance were investigated in vivo and in vitro., Results: Overexpression of CHD1L was significantly associated with tumour microsatellite formation (p = 0.045), advanced tumour stage (p = 0.018), overall survival time (p = 0.002), overall survival time of patients who received transarterial chemoembolisation treatment (p = 0.028) and chemoresistance (p = 0.020) in HCC. Interestingly, CHD1L could inhibit apoptosis induced by 5-fluorourail (5-FU) but not doxorubicin. The mechanistic study revealed that the involvement of the Nur77-mediated pathway in chemotherapeutic agent-induced apoptosis can dictate if CHD1L could confer resistance to chemotherapy. Furthermore, an adenoviral vector containing short hairpin RNAs against CHD1L (CHD1L-shRNAs) could suppress cell growth, clonogenicity and chemoresistance to 5-FU. An in vivo study found that CHD1L-shRNAs could inhibit xenograft tumour growth and increase the sensitivity of tumour cells to 5-FU in nude mice., Conclusions: This study highlighted for the first time the prognostic value of CHD1L in HCC and the potential application of virus-mediated CHD1L silencing in HCC treatment.
- Published
- 2011
- Full Text
- View/download PDF
199. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells.
- Author
-
Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X, and Lu L
- Subjects
- Animals, B-Cell Activating Factor metabolism, B-Lymphocyte Subsets metabolism, B-Lymphocytes metabolism, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Gene Expression, Gene Expression Regulation immunology, Interleukin-10 immunology, Mice, Oligonucleotide Array Sequence Analysis, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factor AP-1 biosynthesis, Transcription Factor AP-1 immunology, B-Cell Activating Factor immunology, B-Lymphocyte Subsets immunology, B-Lymphocytes immunology, Cell Differentiation immunology, Interleukin-10 biosynthesis
- Abstract
Although B cells have been shown to possess a regulatory function, microenvironmental factors or cytokines involved in the induction of regulatory B cells remain largely uncharacterized. B cell-activating factor (BAFF), a member of TNF family cytokines, is a key regulator for B cell maturation and function. In this study, we detected significantly increased numbers of IL-10-producing B cells in BAFF-treated B cell cultures, an effect specifically abrogated by neutralization of BAFF with TACI-Fc. BAFF-induced IL-10-producing B cells showed a distinct CD1d(hi)CD5(+) phenotype, which were mainly derived from marginal zone B cells. Moreover, BAFF activated transcription factor AP-1 for binding to IL-10 promoter. Notably, BAFF treatment in vivo increased the number of IL-10-producing B cells in marginal zone regions. Furthermore, BAFF-induced IL-10-producing B cells possess a regulatory function both in vitro and in vivo. Taken together, our findings identify a novel function of BAFF in the induction of IL-10-producing regulatory B cells.
- Published
- 2010
- Full Text
- View/download PDF
200. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population.
- Author
-
Chen DQ, Zeng Y, Zhou J, Yang L, Jiang S, Huang JD, Lu L, and Zheng BJ
- Subjects
- Adult, Asian People, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Point Mutation, White People, Genetic Predisposition to Disease, Hepatitis B, Chronic genetics, Polymorphism, Genetic
- Abstract
A number of genetic loci have been proposed to be associated with persistent hepatitis B virus (HBV) infection. This study aimed to evaluate the association and interaction of susceptible genes with HBV persistence in a Chinese population. A total of 17 polymorphisms in 9 candidate genes were studied in 361 Chinese chronic hepatitis B patients and 304 patients who recovered spontaneously. Distributions of susceptible polymorphisms were examined in healthy Chinese and Caucasian populations. Gene-gene interactions were tested by the multifactor dimensionality reduction (MDR) method. The TNF -308 G/G genotype and G allele, IL-10RB codon 47 A allele, and MCP-1 -2518 G/G genotype and G allele were more frequent in patients than controls (P < 0.01, after multiple corrections Pc < 0.05), while the frequencies of TNF -308 A/G genotype and IL-10 -592 A/A genotype were significantly higher in controls than in the patient group (Pc < 0.05). The frequencies of the risk allele MCP-1 -2518 G and CTLA4 6230 G were much higher in Chinese than in the Caucasian groups (P < 0.001). An interaction between CCR5 -2459, TNFA -863, IL-10RB codon 47, and MCP-1 -2518 was detected by MDR (P = 0.001). The results indicate that genetic determinants may affect the outcome of HBV infection in both independent and synergic manners. J. Med. Virol. 82:371-378, 2010. (c) 2010 Wiley-Liss, Inc.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.